bnt162b2 booster dose immunization Search Results


90
BioNTech bnt162b1 vaccine
Antibody persistence 3 and 6 months after the first dose of <t> BNT162b1 </t> vaccination
Bnt162b1 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b1 vaccine/product/BioNTech
Average 90 stars, based on 1 article reviews
bnt162b1 vaccine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioNTech bnt162b2 xbb.1.5
Antibody persistence 3 and 6 months after the first dose of <t> BNT162b1 </t> vaccination
Bnt162b2 Xbb.1.5, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 xbb.1.5/product/BioNTech
Average 90 stars, based on 1 article reviews
bnt162b2 xbb.1.5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Pfizer Inc mrna vaccine pfizer bnt162b2
Antibody persistence 3 and 6 months after the first dose of <t> BNT162b1 </t> vaccination
Mrna Vaccine Pfizer Bnt162b2, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mrna vaccine pfizer bnt162b2/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
mrna vaccine pfizer bnt162b2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Wolters Kluwer Health bnt162b2
Antibody persistence 3 and 6 months after the first dose of <t> BNT162b1 </t> vaccination
Bnt162b2, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Moderna mrna sars-cov-2 vaccination spikevax
Antibody persistence 3 and 6 months after the first dose of <t> BNT162b1 </t> vaccination
Mrna Sars Cov 2 Vaccination Spikevax, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mrna sars-cov-2 vaccination spikevax/product/Moderna
Average 90 stars, based on 1 article reviews
mrna sars-cov-2 vaccination spikevax - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Moderna triple-mrna vaccination mrna 1273
Antibody persistence 3 and 6 months after the first dose of <t> BNT162b1 </t> vaccination
Triple Mrna Vaccination Mrna 1273, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/triple-mrna vaccination mrna 1273/product/Moderna
Average 90 stars, based on 1 article reviews
triple-mrna vaccination mrna 1273 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioNTech comirnaty

Comirnaty, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/comirnaty/product/BioNTech
Average 90 stars, based on 1 article reviews
comirnaty - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioNTech bnt162b6

Bnt162b6, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b6/product/BioNTech
Average 90 stars, based on 1 article reviews
bnt162b6 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Moderna spikevax
Effect of <t> mRNA vaccination </t> on POTS symptoms.
Spikevax, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spikevax/product/Moderna
Average 90 stars, based on 1 article reviews
spikevax - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Pfizer Inc sars-cov-2 pfizer-bnt-162b2 vaccination
Effect of <t> mRNA vaccination </t> on POTS symptoms.
Sars Cov 2 Pfizer Bnt 162b2 Vaccination, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sars-cov-2 pfizer-bnt-162b2 vaccination/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
sars-cov-2 pfizer-bnt-162b2 vaccination - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Moderna messenger rna vaccination moderna 1273
Effect of <t> mRNA vaccination </t> on POTS symptoms.
Messenger Rna Vaccination Moderna 1273, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/messenger rna vaccination moderna 1273/product/Moderna
Average 90 stars, based on 1 article reviews
messenger rna vaccination moderna 1273 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Siemens Healthineers bnt 162b2 vaccine
Effect of <t> mRNA vaccination </t> on POTS symptoms.
Bnt 162b2 Vaccine, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt 162b2 vaccine/product/Siemens Healthineers
Average 90 stars, based on 1 article reviews
bnt 162b2 vaccine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Antibody persistence 3 and 6 months after the first dose of  BNT162b1  vaccination

Journal: Advances in Therapy

Article Title: Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial

doi: 10.1007/s12325-022-02206-1

Figure Lengend Snippet: Antibody persistence 3 and 6 months after the first dose of BNT162b1 vaccination

Article Snippet: This study further extends our understanding of immune persistence and the safety of the BNT162b1 vaccine as a candidate vaccine in the BioNTech pipeline.

Techniques: Virus

Longitudinal geometric mean titer of virus-neutralizing antibody, anti-S1 IgG and anti-RBD IgG in healthy participants over 6 months. A GMT of neutralizing SARS-CoV-2 antibodies. B GMT of anti-S1 antibodies. C GMT of anti-RBD antibodies. Participants received two doses of BNT162b1 (10 or 30 µg) or placebo (saline) on days 1 and 22. Blood samples were not collected from older participants (aged 65–85 years) at day 8 and 3 months after dose 1. The error bar was standard error. anti-RBD IgG antibody to receptor binding domain, anti-S1 IgG antibody to S1 protein, GMT geometric mean titer, SARS-CoV-2 severe acute respiratory syndrome coronavirus 2

Journal: Advances in Therapy

Article Title: Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial

doi: 10.1007/s12325-022-02206-1

Figure Lengend Snippet: Longitudinal geometric mean titer of virus-neutralizing antibody, anti-S1 IgG and anti-RBD IgG in healthy participants over 6 months. A GMT of neutralizing SARS-CoV-2 antibodies. B GMT of anti-S1 antibodies. C GMT of anti-RBD antibodies. Participants received two doses of BNT162b1 (10 or 30 µg) or placebo (saline) on days 1 and 22. Blood samples were not collected from older participants (aged 65–85 years) at day 8 and 3 months after dose 1. The error bar was standard error. anti-RBD IgG antibody to receptor binding domain, anti-S1 IgG antibody to S1 protein, GMT geometric mean titer, SARS-CoV-2 severe acute respiratory syndrome coronavirus 2

Article Snippet: This study further extends our understanding of immune persistence and the safety of the BNT162b1 vaccine as a candidate vaccine in the BioNTech pipeline.

Techniques: Virus, Saline, Binding Assay

Journal: Advances in Therapy

Article Title: Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial

doi: 10.1007/s12325-022-02206-1

Figure Lengend Snippet:

Article Snippet: This study further extends our understanding of immune persistence and the safety of the BNT162b1 vaccine as a candidate vaccine in the BioNTech pipeline.

Techniques: Transmission Assay, Formulation, Generated

Journal: European Heart Journal: Case Reports

Article Title: Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report

doi: 10.1093/ehjcr/ytad063

Figure Lengend Snippet:

Article Snippet: A 59-year-old male with no medical history complained of chest pain a day after receiving the first dose of COVID-19 mRNA (BNT162b2) vaccination (Comirnaty, BioNTech/Pfizer) and was admitted to an affiliated hospital 3 days after this vaccination.

Techniques: Magnetic Resonance Imaging

Effect of  mRNA vaccination  on POTS symptoms.

Journal: F1000Research

Article Title: Tolerability of COVID-19 mRNA vaccines in patients with postural tachycardia syndrome: a cross-sectional study

doi: 10.12688/f1000research.109373.1

Figure Lengend Snippet: Effect of mRNA vaccination on POTS symptoms.

Article Snippet: The present study investigated the frequencies of known side effects of mRNA vaccination (Spikevax ® , Moderna; BNT162b2 ® , Pfizer) in patients with POTS.

Techniques: Concentration Assay